NuVascular Technologies and Worcester Polytechnic Institute commercializing stem cell treatment to repair heart damage

NuVascular Technologies, Inc. has recently obtained exclusive licensing rights to commercialize a breakthrough medical device that will provide a minimally invasive treatment for heart disease, the No. 1 cause of death in the United States accounting for one in every four deaths.

The BioGenerator stem cell device allows the heart to repair itself and could improve heart function in as little as two to four weeks. NuVascular Technologies is teaming up with researchers at both …

Delivery of stem cells into heart muscle after heart attack may enhance cardiac repair and reverse injury

As seen in Science Daily October 19, 2014

Summary:
Delivering stem cell factor directly into damaged heart muscle after a heart attack may help repair and regenerate injured tissue. A novel SCF gene transfer delivery system induced the recruitment and expansion of adult c-Kit positive (cKit+) cardiac stem cells to injury sites that reversed heart attack damage in a pre-clinical model. In addition, the gene therapy improved cardiac function, decreased heart muscle cell death, increased …